01.04.2011 • News

China's BlueStar Wins EU Okay To Buy Orkla Unit

Chinese state-run chemicals company China National BlueStar secured EU regulatory approval on Friday to buy Norwegian conglomerate Orkla's silicon division Elkem for $2 billion.

The acquisition will give BlueStar, which is backed by U.S. private equity firm Blackstone Group, access to technology that could help China reduce its emissions of greenhouse gases.

The EU's competition chief Joaquin Almunia said in a statement: "Even assuming all Chinese state-owned firms in the sector acted as one, European consumers would still enjoy sufficient competition from other players serving the market."

Elkem, which produces high-grade silicon for the solar industry and computers, has production facilities in Europe, North and South America, Africa and Asia.
Other strong players serving European consumers include FerroAtlantica of Spain, Dow Corning of the United States and Germany's Wacker, the EU competition watchdog said.

 

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.